Novasep, a maker of purification products for life science molecules controlled by European private equity firms Gilde and Banexi, has completed a €310m recapitalisation backed by French state-backed growth vehicle Fonds Stratégique d'Investissement.

Index Ventures has partnered with pharmaceutical giants GlaxoSmithKline and Johnson & Johnson for the launch of a €150m fund, marking the London-based venture capital firm’s first vehicle solely dedicated to making investments in the life sciences sector.